You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 76 No. 5, NOVEMBER 1945 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (49)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

STREPTOMYCIN FOR CERTAIN SYSTEMIC INFECTIONS AND ITS EFFECT ON THE URINARY AND FECAL FLORA

HOBART A. REIMANN, M.D.; ALISON H. PRICE, M.D.; WILLIAM F. ELIAS, Ph.D.

Arch Intern Med. 1945;76(5):269-277.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Streptomycin, an antibiotic substance derived from Actinomyces griseus, when injected parenterally appears in the blood, urine and spinal fluid in amounts theoretically bacteriostatic or bactericidal for certain gram-negative bacilli known to be resistant to penicillin and to sulfonamide compounds.1 When given orally, only traces appear in the blood and urine, since most of it is excreted in the feces, where it exerts a suppressive effect on various bacteria. It is relatively nontoxic. These facts, together with suggestive evidence of the therapeutic value of streptomycin in several cases of typhoid1a and in experimental infections in animals,2 warrants further trial of the drug in several directions; namely, (a) for more patients with typhoid; (b) for infections caused by gram-negative bacilli, especially brucellosis, bacillary dysentery, tularemia, plague, cholera and Escherichia coli and Hemophilus influenzae infections; (c) for infections of the urinary tract, and (d) to study its effect on the . . . [Full Text PDF of this Article]


Author Affiliations

PHILADELPHIA

From the Jefferson Medical College and Hospital (Dr. Reimann and Dr. Price) and the Wyeth Institute of Applied Biochemistry (Dr. Elias).


Footnotes

Streptomycin hydrochloride was generously supplied by Merck & Co., Inc., Rahway, N. J. Mrs. Jane Durso assisted with the technical details of the study.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1945 American Medical Association. All Rights Reserved.